Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease

Li,Da-Wei; Yao,Min; Dong,Yan-Hua; Tang,Min-Na; Chen,Wei; Li,Guang-Ren; Sun,Bi-Quan

doi:10.3892/ijmm.2014.1904

Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease

Authors:
- Da-Wei Li
- Min Yao
- Yan-Hua Dong
- Min-Na Tang
- Wei Chen
- Guang-Ren Li
- Bi-Quan Sun
View Affiliations

Affiliations: Department of Neurology, Affiliated Hospital of Beihua University, Jilin City, Jilin, P.R. China, Department of Neurology, The Third Hospital of Jilin University, Changchun, Jilin, P.R. China
Published online on: August 19, 2014 https://doi.org/10.3892/ijmm.2014.1904
Pages: 1358-1364

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The mitochondria are the most important cytoplasmic organelles in determining cell survival and death. Mitochondrial dysfunction leads to a wide range of disorders, including neurodegenerative diseases. The central events in the mitochondrial‑dependent cell death pathway are the activation of the mitochodrial permeability transition pore (mPTP) and the disruption of mitochondrial membrane potential, which cause the release of apoptogenic molecules and finally lead to cell death. This is thought to be at least partly responsible for the loss of dopaminergic neurons in Parkinson's disease (PD); thus, the attenuation of mitochondrial dysfunction may contribute to alleviating the severity and progression of this disease. Guanosine is a pleiotropic molecule affecting multiple cellular processes, including cellular growth, differentiation and survival. Its protective effects on the central nervous system and and on several cell types by inhibiting apoptosis have been shown in a number of pathological conditions. This study aimed to analyze the ability of guanosine to protect neuronal PC12 cells from the toxicity induced by 1-methyl-4-phenylpyridinium (MPP+), the active metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which mediates selective damage to dopaminergic neurons and causes irreversible Parkinson-like symptoms in humans and primates. Our results demonstrated that the apoptosis of PC12 cells induced by MPP+ was significantly prevented by pre-treatment for 3 h with guanosine. In addition, guanosine attenuated the MPP+-induced collapse of mitochondrial transmembrane potential and prevented the sebsequent activation of caspase-3, thereby protecting dopaminergic neurons against mitochondrial stress-induced damage.

View Figures

View References

1	Forno LS: Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol. 55:259–272. 1996.
2	Abou-Sleiman PM, Muqit MM and Wood NW: Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nat Rev Neurosci. 7:207–219. 2006.
3	McGeer PL and McGeer EG: Glial reactions in Parkinson’s disease. Mov Disord. 23:474–483. 2008.
4	Olanow CW: The pathogenesis of cell death in Parkinson’s disease - 2007. Mov Disord. 22(Suppl 17): S335–S342. 2007.
5	Zhou C, Huang Y and Przedborski S: Oxidative stress in Parkinson’s disease: a mechanism of pathogenic and therapeutic significance. Ann NY Acad Sci. 1147:93–104. 2008.
6	Li DW, Liu ZQ, Chen W, Yao M and Li GR: Association of glycogen synthase kinase-3β with Parkinson’s disease (Review). Mol Med Rep. 9:2043–2050. 2014.
7	Vila M and Przedborski S: Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci. 4:365–375. 2003. View Article : Google Scholar : PubMed/NCBI
8	Perier C, Tieu K, Guégan C, et al: Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc Natl Acad Sci USA. 102:19126–19131. 2005. View Article : Google Scholar : PubMed/NCBI
9	Roucou X and Martinou JC: Conformational change of Bax: a question of life or death. Cell Death Differ. 8:875–877. 2001. View Article : Google Scholar : PubMed/NCBI
10	Shiba-Fukushima K, Imai Y, Yoshida S, et al: PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy. Sci Rep. 2:10022012. View Article : Google Scholar : PubMed/NCBI
11	Kopin IJ and Markey SP: MPTP toxicity: implications for research in Parkinson’s disease. Annu Rev Neurosci. 11:81–96. 1988.
12	Heikkila RE, Sieber BA, Manzino L and Sonsalla PK: Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Mol Chem Neuropathol. 10:171–183. 1989. View Article : Google Scholar : PubMed/NCBI
13	Calon F, Lavertu N, Lemieux AM, et al: Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter. Synapse. 40:225–234. 2001. View Article : Google Scholar : PubMed/NCBI
14	Chiba K, Trevor A and Castagnoli N Jr: Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun. 120:574–578. 1984. View Article : Google Scholar : PubMed/NCBI
15	Rathbone MP, Middlemiss PJ, Gysbers JW, et al: Trophic effects of purines in neurons and glial cells. Prog Neurobiol. 59:663–690. 1999. View Article : Google Scholar : PubMed/NCBI
16	Dal-Cim T, Martins WC, Santos AR and Tasca CI: Guanosine is neuroprotective against oxygen/glucose deprivation in hippocampal slices via large conductance Ca²⁺-activated K⁺ channels, phosphatidilinositol-3 kinase/protein kinase B pathway activation and glutamate uptake. Neuroscience. 183:212–220. 2011. View Article : Google Scholar : PubMed/NCBI
17	Chang R, Algird A, Bau C, Rathbone MP and Jiang S: Neuro-protective effects of guanosine on stroke models in vitro and in vivo. Neurosci Lett. 431:101–105. 2008. View Article : Google Scholar : PubMed/NCBI
18	Di Iorio P, Ballerini P, Traversa U, et al: The antiapoptotic effect of guanosine is mediated by the activation of the PI 3-kinase/AKT/PKB pathway in cultured rat astrocytes. Glia. 46:356–368. 2004.PubMed/NCBI
19	Pettifer KM, Kleywegt S, Bau CJ, et al: Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis. Neuroreport. 15:833–836. 2004. View Article : Google Scholar : PubMed/NCBI
20	Pettifer KM, Jiang S, Bau C, et al: MPP(+)-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine. Purinergic Signal. 3:399–409. 2007. View Article : Google Scholar : PubMed/NCBI
21	Li DW, Li GR, Lu Y, et al: α-lipoic acid protects dopaminergic neurons against MPP⁺-induced apoptosis by attenuating reactive oxygen species formation. Int J Mol Med. 32:108–114. 2013.
22	Yim SB, Park SE and Lee CS: Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells. J Pharmacol Exp Ther. 321:816–822. 2007. View Article : Google Scholar : PubMed/NCBI
23	Banerjee R, Vitvitsky V and Garg SK: The undertow of sulfur metabolism on glutamatergic neurotransmission. Trends Biochem Sci. 33:413–419. 2008. View Article : Google Scholar : PubMed/NCBI
24	Fischer U, Jänicke RU and Schulze-Osthoff K: Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10:76–100. 2003. View Article : Google Scholar : PubMed/NCBI
25	de Lau LM and Breteler MM: Epidemiology of Parkinson’s disease. Lancet Neurol. 5:525–535. 2006.
26	Budd SL and Nicholls DG: Mitochondria in the life and death of neurons. Essays Biochem. 33:43–52. 1998.PubMed/NCBI
27	Akhtar RS, Ness JM and Roth KA: Bcl-2 family regulation of neuronal development and neurodegeneration. Biochim Biophys Acta. 1644:189–203. 2004. View Article : Google Scholar : PubMed/NCBI
28	Armstrong JS: Mitochondrial membrane permeabilization: the sine qua non for cell death. Bioessays. 28:253–260. 2006. View Article : Google Scholar : PubMed/NCBI
29	Martinou JC and Green DR: Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol. 2:63–67. 2001. View Article : Google Scholar : PubMed/NCBI
30	Gollapudi S, McCormick MJ and Gupta S: Changes in mitochondrial membrane potential and mitochondrial mass occur independent of the activation of caspase-8 and caspase-3 during CD95-mediated apoptosis in peripheral blood T cells. Int J Oncol. 22:597–600. 2003.PubMed/NCBI
31	Tarozzi A, Merlicco A, Morroni F, et al: Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers. J Biol Regul Homeost Agents. 24:297–306. 2010.PubMed/NCBI
32	Molz S, Dal-Cim T, Budni J, et al: Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition. J Neurosci Res. 89:1400–1408. 2011.PubMed/NCBI
33	Chuang DM, Chen RW, Chalecka-Franaszek E, et al: Neuro-protective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord. 4:129–136. 2002. View Article : Google Scholar : PubMed/NCBI
34	Chen RW and Chuang DM: Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem. 274:6039–6042. 1999. View Article : Google Scholar : PubMed/NCBI
35	Manji HK and Chen G: PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry. 7(Suppl 1): S46–S56. 2002. View Article : Google Scholar : PubMed/NCBI
36	Chen G, Zeng WZ, Yuan PX, et al: The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem. 72:879–882. 1999. View Article : Google Scholar : PubMed/NCBI
37	Kaga S, Zhan L, Altaf E and Maulik N: Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol. 40:138–147. 2006. View Article : Google Scholar
38	Boatright KM and Salvesen GS: Mechanisms of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003. View Article : Google Scholar : PubMed/NCBI
39	Kumar S: Caspase function in programmed cell death. Cell Death Differ. 14:32–43. 2007. View Article : Google Scholar
40	Navarro A, Boveris A, Bandez MJ, et al: Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radic Biol Med. 46:1574–1580. 2009. View Article : Google Scholar : PubMed/NCBI
41	Cassarino DS, Fall CP, Swerdlow RH, et al: Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson’s disease. Biochim Biophys Acta. 1362:77–86. 1997.PubMed/NCBI
42	Wallace DC: A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 39:359–407. 2005. View Article : Google Scholar : PubMed/NCBI
43	Halliwell B: Oxidative stress and neurodegeneration: where are we now? J Neurochem. 97:1634–1658. 2006. View Article : Google Scholar : PubMed/NCBI
44	Lee M, Cho T, Jantaratnotai N, Wang YT, McGeer E and McGeer PL: Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J. 24:2533–2545. 2010. View Article : Google Scholar : PubMed/NCBI
45	Hall AG: Review: The role of glutathione in the regulation of apoptosis. Eur J Clin Invest. 29:238–245. 1999. View Article : Google Scholar : PubMed/NCBI